If you live in Korea and eat Korean food, you’re already getting isoflavones daily. Adding supplements raises a reasonable question: does the total add up to something worth thinking about?
The answer requires knowing what your baseline actually is — and the survey data on that produced two surprises.
The baseline, and why two numbers appear
A study analysed dietary intake data from 21,271 participants in the Korea National Health and Nutrition Examination Survey (2016–2018)[1].
It reports two figures, and the gap between them is instructive.
- Mean total isoflavone intake: 139.27 mg/day
- Usual intake: 47.44 mg/day[1]
The first is an average across single-day dietary recalls. The second is a statistical estimate of habitual intake, adjusted for the fact that any one day is unrepresentative.
Usual intake is the more meaningful number for a personal baseline. A single day’s average gets pulled upward by people who happened to eat a large soy-heavy meal that day. Habitual intake smooths that out.
So roughly 47 mg daily is the working figure for a typical Korean diet.
A bit more detail — on why the two differ so much. Day-to-day variation in isoflavone intake is enormous, because it depends on whether a particular meal contained legumes. The study estimated within-participant and between-participant variance separately to correct for this. When day-to-day swings are large relative to differences between people, a single-day average will substantially overstate what any individual habitually consumes.
The largest source isn’t soy
Here’s the finding I didn’t expect.
Legumes contributed 91% of isoflavone intake overall. But broken down by individual food[1]:
- Arrowroot: 67.2%
- Soybean: 21.3%
- Bean sprouts: 5.4%
- Tofu: 2.1%
Arrowroot accounts for two-thirds. Soybean, bean sprouts and tofu together come to under 30%.
That reorders the mental picture considerably. Tofu — the food most associated with soy isoflavones in Western discussion — contributes about one fiftieth of the total in this dataset.
It also means intake varies enormously by individual habit. Someone who drinks arrowroot preparations regularly and someone who doesn’t are in very different positions, regardless of how much tofu each eats.
Intake peaks exactly when supplements are marketed
The age pattern is worth noting.
Usual isoflavone intake was highest in participants aged 50 to 64, rising with age up to that band and declining thereafter[1].
That’s precisely the age group targeted by menopause-related isoflavone supplements.
So the marketing premise — that this group needs supplementation to obtain isoflavones — sits awkwardly beside the data showing they already consume more than any other age group.
| Measure | Figure |
| Sample size | 21,271 |
| Mean intake (single-day recall) | 139.27 mg/day |
| Usual (habitual) intake | 47.44 mg/day |
| Legumes as food group | 91% of total |
| Arrowroot | 67.2% |
| Soybean | 21.3% |
| Peak intake age band | 50–64 years |
[Table 1] Korean isoflavone intake at a glance · Source: KNHANES 2016–2018 Analysis[1]
What adding a supplement does to the total
A typical soy isoflavone supplement supplies somewhere in the range of 30 to 80 mg daily. The exact figure depends on the product and how it’s expressed. As covered in the label post, whether it refers to aglycone or glycoside form changes the number substantially.
It’s worth noting that estimates of the Korean baseline have varied by method. An earlier study using a food frequency questionnaire put average adult intake at 23.1 mg/day[3] — roughly half the KNHANES usual-intake figure. Different instruments, different answers.
Add that to a habitual dietary intake around 47 mg and the combined total lands meaningfully higher than either alone.
Whether that matters depends on questions this post can’t answer for you. But two things are worth stating plainly.
First, the trials were conducted in populations with much lower baselines. Most isoflavone intervention research was done in Western cohorts, where habitual intake is a fraction of the Korean figure. A trial giving 50 mg to someone consuming 2 mg daily is testing a different intervention from giving 50 mg to someone already consuming 47 mg.
That’s a specific instance of a general problem: supplementation trials measure the effect of an increment, and the increment means different things at different baselines.
Second, the approved claim in Korea isn’t about menopause anyway. As covered in the regulatory comparison post, soy isoflavone is recognised here under joint and bone health, not menopausal symptoms. So a Korean product’s approved wording and the reason many people buy it aren’t the same thing.
How to judge added need
Some practical structure, without prescribing a diet.
Estimate your own baseline roughly. The population average is 47 mg, but the arrowroot finding means individual variation is wide. If you rarely eat legumes, your baseline is well below average. If arrowroot preparations are part of your routine, well above.
Check what the supplement actually supplies. Aglycone versus glycoside expression changes the number, sometimes by a factor approaching two.
Note that Korea’s daily intake standard exists. The approved ingredient has a specified daily intake range, checkable on the official portal[2] — and as covered in the upper intake post, that range has an upper bound as well as a lower one.
Raise it with a clinician if you have a hormone-sensitive condition. Isoflavones have oestrogenic properties. EFSA’s safety panel assessed potential effects on the mammary gland, uterus and thyroid in peri- and post-menopausal women specifically. That assessment is separate from any efficacy question and belongs in a clinical conversation.
Don’t restrict dietary soy to make room for a supplement. That inverts the sensible order — the food comes with fibre, protein and everything else in the legume.
Closing
Two things reframed this for me.
Arrowroot, not tofu. Two-thirds of Korean isoflavone intake comes from a source that barely features in English-language discussion of the subject. Anyone estimating their intake from a Western food table would get it badly wrong.
And the peak is at 50 to 64 — the exact demographic that isoflavone supplements are sold to. Which doesn’t mean supplementation is pointless for everyone in that band, but it does mean “you’re not getting enough” is a claim that needs checking against a baseline rather than assumed.
The broader point recurs across this series. Trials measure increments, and an increment added to 2 mg is a different intervention from the same increment added to 47.
Key Terms
- Isoflavone — a plant compound found mainly in legumes, structurally similar enough to oestrogen to interact with its receptors.
- Usual intake — a statistical estimate of habitual daily consumption, corrected for day-to-day variation. More meaningful than a single-day average.
- Aglycone — the form with the sugar removed. Supplement labels may express content as aglycone or as the sugar-attached glycoside, and the numbers differ substantially.
- Baseline — how much of something you already consume before adding a supplement.
At a Glance
- KNHANES analysis of 21,271 participants reports mean intake 27 mg/day but usual intake 47.44 mg/day
- Usual intake is the more meaningful personal baseline
- Legumes supply 91% of the total, but arrowroot alone accounts for 67.2%
- Soybean 21.3%, bean sprouts 5.4%, tofu just 2.1%
- Usual intake peaks at ages 50–64 — the group most targeted by menopause supplements
- Most intervention trials were run in populations with far lower baselines
- Korea’s approved claim for soy isoflavone covers bone and joint health, not menopause
- Individual variation is wide, driven largely by arrowroot consumption
※ This article is for general information and does not replace medical advice, and it does not recommend restricting or increasing any food. Isoflavones have oestrogenic properties and may interact with thyroid function. If you have a hormone-sensitive condition, thyroid disease, or take related medication, consult a clinician before taking any isoflavone supplement. Approved ingredients and intake standards are revised periodically — confirm current details on official sources.
References
- “Usual intake of dietary isoflavone and its major food sources in Koreans: Korea National Health and Nutrition Examination Survey 2016–2018 data”, Nutrition Research and Practice 2022;16(S1):S134, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127517
- Food Safety Korea (MFDS), recognised functional ingredient and daily intake standard lookup, https://www.foodsafetykorea.go.kr/
- “Estimated dietary isoflavone intake among Korean adults” (earlier food-frequency-based estimate), PubMed, https://pubmed.ncbi.nlm.nih.gov/20368940/